Homeostasis model assessment of insulin resistance (HOMA-IR) and metabolic syndrome at baseline of a multicentric Brazilian cohort: ELSA-Brasil study

Abstract

Homeostasis model assessment of insulin resistance (HOMA-IR) is a method to measure insulin resistance. HOMA-IR cut-offs for identifying metabolic syndrome might vary across populations and body mass index (BMI) levels. We aimed to investigate HOMA-insulin resistance cut-offs that best discriminate individuals with insulin resistance and with metabolic syndrome for each BMI category in a large sample of adults without diabetes in the baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Among the 12,313 participants with mean age of 51.2 (SD 8.9) years, the prevalence of metabolic syndrome was 34.6%, and 60.1% had overweight or obesity. The prevalence of metabolic syndrome among normal weight, overweight and obesity categories were, respectively, 13%, 43.2% and 60.7%. The point of maximum combined sensitivity and specificity of HOMA-IR to discriminate the metabolic syndrome was 2.35 in the whole sample, with increasing values at higher BMI categories. This investigation contributes to better understanding HOMA-IR values associated with insulin resistance and metabolic syndrome in a large Brazilian adult sample, and that use of cut-off points according to ROC curve may be the better strategy. It also suggests that different values might be appropriate across BMI categories.

A comprehensive investigation of novel and traditional inflammatory and metabolic markers as predictive indicators in psoriasis

“…Our objective was to assess the potential of HOMA-IR as a reliable marker for psoriasis. 31,32 Consistent with previous studies, our study revealed a significant increase in HOMA-IR among psoriatic patients (P = 0.016). In the study of Bari et al, a statistically significant positive correlation was mentioned between HOMA-IR and PASI.…”

Association Between Aspartate Aminotransferase to Alanine Aminotransferase Ratio and Incidence of Type 2 Diabetes Mellitus in the Japanese Population: A Secondary Analysis of a Retrospective Cohort Study

“…One of the alternative ways to assess IR is the Homeostatic Model Assessment of insulin resistance (HOMA-IR), which is calculated from fasting plasma glucose (FPG) and immunoreactive insulin (IRI). 3 However, measurement of insulin is not a routine test, and screening for patients of prediabetes state is arduous. So, it is necessary to develop another feasible way to screen younger adults for prediabetes and initiate early prevention programs for high-risk populations.…”

Insulin resistance measured by High Homeostasis Model Assessment (HOMA) as a Predictor for new onset Diabetes mellitus and diabetic Complications in Non-Diabetic Adults: A KoGES prospective Cohort Study

“…BMI is a metabolic disease parameter and is associated with IR and diabetes [17]. In our study, BMI was found to be a signi cant risk factor for new onset DM but not for vascular events.…”